About
In the worst case, counterfeit drugs are life-threatening - in the best case, they remain ineffective. In any case, however, they cost the national economy billions. For this reason, since February 9, 2019, prescription drug packages have been secured with the initial opening protection provided by the EU Anti-Counterfeiting Directive and an individual package number.
This product is intended for
- Head of Supply Chain Management
- Head of Information Technology
- Product Manager
- Production Manager
- Line Producer
- Head of Operations
Media
Products media viewer
-
Healthcare: Our Counterfeit Protection approach with Serialization and Track & Trace
We support you in implementing the Serialization and Track & Trace requirements for the healthcare market. Download our White Paper "Serialization of Medications in EU" and learn more about our experience and how we can help you to reach the requirements. https://arva.to/r42kW